RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 22 - per page Next page
Order by
Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More
Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More
tesa AG, based in Hamburg, has acquired Labtec Gesellschaft für technologische Forschung und Entwicklung mbH More
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund. More
Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More
With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More
Exotic Naturals announces the launch of E-DM-13, a Support formula for Diabetics. An innovative research formula, which is not only clinically proven to lower blood sugar levels but also controls serum nitrotyrosin, a key indicator for atherosclerotic dis More
Dr David Rees becomes Director of Medicinal Chemistry at Astex More
Canada's lacklustre pace in adopting health innovations and commercializing new products and processes is costing our health system, according to organizers of a Richard Ivey School of Business conference taking place next week. More
Displaying 1..10 of 22 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us